Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones12-03

This article was automatically generated using Dow Jones technology.

Shares of Genmab A/S advanced 1.7% to DKK1,551.50 Monday on what proved to be an overall favorable trading session for the stock market, with the OMX Nordic 40 Index rising 1.5% to 2,663.11.

This was the stock's fourth consecutive day of gains.

The company closed DKK731.50 short of its 52-week high of DKK2,283.00, which the company achieved on December 11, 2023.

Trading volume was 107,473, compared to the 50-day average trading volume of 106,053.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

December 02, 2024 12:02 ET (17:02 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment